Department of Neurology, National Neuroscience Institute, Tan Tock Seng Hospital, Singapore.
Neuroscience Academic Clinical Program, Duke-NUS Medical School, Singapore.
J Parkinsons Dis. 2023;13(2):233-242. doi: 10.3233/JPD-225095.
Diffusion kurtosis imaging provides in vivo measurement of microstructural tissue characteristics and could help guide management of Parkinson's disease.
To investigate longitudinal diffusion kurtosis imaging changes on magnetic resonance imaging in the deep grey nuclei in people with early Parkinson's disease over two years, and whether they correlate with disease progression.
We conducted a longitudinal case-control study of early Parkinson's disease. 262 people (Parkinson's disease: n = 185, aged 67.5±9.1 years; 43% female; healthy controls: n = 77, aged 66.6±8.1 years; 53% female) underwent diffusion kurtosis imaging and clinical assessment at baseline and two-year timepoints. We automatically segmented five nuclei, comparing the mean kurtosis and other diffusion kurtosis imaging indices between groups and over time using repeated-measures analysis of variance, and Pearson correlation with the two-year change in Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III.
At baseline, mean kurtosis was higher in Parkinson's disease than controls in the substantia nigra, putamen, thalamus and globus pallidus when adjusting for age, sex, and levodopa equivalent daily dose (p < 0.027). These differences grew over two years, with mean kurtosis increasing for the Parkinson's disease group while remaining stable for the control group; evident in significant "group ×time" interaction effects for the putamen, thalamus and globus pallidus (ηp2= 0.08-0.11, p < 0.015). However, we did not detect significant correlations between increasing mean kurtosis and declining motor function in the Parkinson's disease group.
Diffusion kurtosis imaging of specific grey matter structures shows abnormal microstructure in PD at baseline and abnormal progression in PD over two years.
扩散峰度成像是一种活体测量微观结构组织特征的方法,有助于指导帕金森病的治疗。
研究两年内早期帕金森病患者磁共振成像深部灰质核内的扩散峰度成像变化及其与疾病进展的关系。
我们进行了一项早期帕金森病的纵向病例对照研究。262 人(帕金森病组:n=185,年龄 67.5±9.1 岁;43%为女性;健康对照组:n=77,年龄 66.6±8.1 岁;53%为女性)分别在基线和两年时进行扩散峰度成像和临床评估。我们使用重复测量方差分析自动对 5 个核团进行分段,比较组间和时间上的平均峰度和其他扩散峰度成像指标,并与两年内运动障碍协会统一帕金森病评定量表第三部分的变化进行 Pearson 相关分析。
基线时,调整年龄、性别和左旋多巴等效日剂量后,帕金森病组黑质、壳核、丘脑和苍白球的平均峰度高于对照组(p<0.027)。这些差异在两年内逐渐增大,帕金森病组的平均峰度增加,而对照组保持稳定;壳核、丘脑和苍白球的“组×时间”交互作用显著(ηp2=0.08-0.11,p<0.015)。然而,我们未发现帕金森病组平均峰度增加与运动功能下降之间存在显著相关性。
特定灰质结构的扩散峰度成像显示帕金森病患者在基线时存在异常的微观结构,且在两年内有异常进展。